Polymorphisms and methylation of the reduced folate carrier in osteosarcoma

Clinical Orthopaedics and Related Research

Volumn 466, Issue 9, 2008, Pages 2046-2051

  Yang, Rui ^a   Qin, Jing ^b,c   Hoang, Bang H ^b,d   Healey, John H ^b   Gorlick, Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; REDUCED FOLATE CARRIER; CARRIER PROTEIN; FOLIC ACID;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MALE; METHYLATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; TRANSCRIPTION REGULATION; ARTICLE; BONE TUMOR; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FEMALE; FOLIC ACID; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; OSTEOSARCOMA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 50649123781     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-008-0323-3     Document Type: Conference Paper

References (30)

1. D Banerjee P Mayer-Kuckuk G Capiaux T Budak-Alpdogan R Gorlick JR Bertino 2002 Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase Biochim Biophys Acta 1587 164 173
2. A Bird 2002 DNA methylation patterns and epigenetic memory Genes Dev 16 6 21
3. DA Day MF Tuite 1998 Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview J Endocrinol 157 361 371
4. AJ Ferreri S Dell'Oro D Capello M Ponzoni P Iuzzolino D Rossi F Pasini A Ambrosetti E Orvieto F Ferrarese G Arrigoni M Foppoli M Reni G Gaidano 2004 Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas Br J Haematol 126 657 664
5. M Gong KH Cowan J Gudas JA Moscow 1999 Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1) Gene 233 21 31
6. R Gorlick E Goker T Trippett M Waltham D Banerjee JR Bertino 1996 Intrinsic and acquired resistance to methotrexate in acute leukemia N Engl J Med 335 1041 1048
7. Y Goto L Yue A Yokoi R Nishimura T Uehara S Koizumi Y Saikawa 2001 A novel single-nucleotide polymorphism in the 3′-untranslated region of the human dihydrofolate reductase gene with enhanced expression Clin Cancer Res 7 1952 1956
8. W Guo JH Healey PA Meyers M Ladanyi AG Huvos JR Bertino R Gorlick 1999 Mechanisms of methotrexate resistance in osteosarcoma Clin Cancer Res 5 621 627
9. PA Jones SB Baylin 2002 The fundamental role of epigenetic events in cancer Nat Rev Genet 3 415 428
10. TK Man M Chintagumpala J Visvanathan J Shen L Perlaky J Hicks M Johnson N Davino J Murray L Helman W Meyer T Triche KK Wong CC Lau 2005 Expression profiles of osteosarcoma that can predict response to chemotherapy Cancer Res 65 8142 8150
11. LH Matherly DI Goldman 2003 Membrane transport of folates Vitam Horm 66 403 456
12. PA Meyers R Gorlick 1997 Osteosarcoma Pediatr Clin North Am 44 973 989
13. PA Meyers R Gorlick G Heller E Casper J Lane AG Huvos JH Healey 1998 Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol J Clin Oncol 16 2452 2458
14. MB Mintz R Sowers KM Brown SC Hilmer B Mazza AG Huvos PA Meyers B Lafleur WS McDonough MM Henry KE Ramsey CR Antonescu W Chen JH Healey A Daluski ME Berens TJ Macdonald R Gorlick DA Stephan 2005 An expression signature classifies chemotherapy-resistant pediatric osteosarcoma Cancer Res 65 1748 1754
15. JA Moscow M Gong R He MK Sgagias KH Dixon SL Anzick PS Meltzer KH Cowan 1995 Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells Cancer Res 55 3790 3794
16. AJ Nataraj I Olivos-Glander N Kusukawa WE Highsmith Jr 1999 Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection Electrophoresis 20 1177 1185
17. PD Prasad S Ramamoorthy FH Leibach V Ganapathy 1995 Molecular cloning of the human placental folate transporter Biochem Biophys Res Commun 206 681 687
18. R Sowers J Toguchida J Qin PA Meyers JH Healey A Huvos D Banerjee JR Bertino R Gorlick 2003 mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma Mol Cancer Ther 2 535 541
19. B Tolner K Roy FM Sirotnak 1998 Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5′ end heterogeneity Gene 211 331 341
20. H Usadel J Brabender KD Danenberg C Jeronimo S Harden J Engles PV Danenberg S Yang D Sidransky 2002 Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 371 375
21. JR Whetstine RM Flatley LH Matherly 2002 The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter Biochem J 367 629 640
22. JR Whetstine LH Matherly 2001 The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element. Basis for tissue-specific gene expression J Biol Chem 276 6350 6358
23. FM Williams WF Flintoff 1995 Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake J Biol Chem 270 2987 2992
24. FM Williams WF Flintoff 1998 Structural organization of the human reduced folate carrier gene: evidence for 5′ heterogeneity in lymphoblast mRNA Somat Cell Mol Genet 24 143 156
25. SC Wong SA Proefke A Bhushan LH Matherly 1995 Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells J Biol Chem 270 17468 17475
26. J Worm AF Kirkin KN Dzhandzhugazyan P Guldberg 2001 Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate- resistant human breast cancer cells J Biol Chem 276 39990 40000
27. R Yang EA Kolb J Qin A Chou R Sowers B Hoang JH Healey AG Huvos PA Meyers R Gorlick 2007 The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate Clin Cancer Res 13 2557 2567
28. R Yang R Sowers B Mazza JH Healey A Huvos H Grier M Bernstein GP Beardsley MD Krailo M Devidas JR Bertino PA Meyers R Gorlick 2003 Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples Clin Cancer Res 9 837 844
29. L Zhang SC Wong LH Matherly 1998 Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons Biochem J 332 773 780
30. R Zhao ID Goldman 2003 Resistance to antifolates Oncogene 22 7431 7457